Introduction
Performance Highlights
Summary of progress during 2009 and objectives for 2010*
CR Framework – Important issues
CR fundamentals – robust processes:
- Policy development and implementation
- Business integrity
- CR audit
- Non-financial reporting
- Stakeholder engagement
2009 Focus
- Improved policy evidence and transparency of implementation
- Local accountability, training and expertise
2009 Progress
- Reviewed our corporate documents, improved intranet communications, and commenced project to further develop guidance and support
- Improved and extended CR communications and specific training in areas such as market risk management, manufacturers’ responsibilities and OHS
2010 Focus
Enhance our risk management processes and roll-out the enhanced Code of Conduct
CR Framework – Important issues
Product stewardship:
- Potentially reduced exposure products
- Ingredients testing and assessment
2009 Focus
- Regulatory demand and product portfolio balance
2009 Progress
- Revised complexity reduction model proposed by cross-functional project team, to reduce product portfolio complexity and improve systems and processes
2010 Focus
Broaden support of consumers, addressing relevant social, quality and product issues
Commence roll-out of complexity reduction programme
CR Framework – Important issues
Responsible sales and marketing:
- International marketing standards
- Youth smoking prevention
- Anti-illicit trade
2009 Focus
- Implementation of revised International Marketing Standards (IMS) and Product Supply Compliance (PSC) policy across the enlarged Group
2009 Progress
- Implemented revised IMS and PSC, and extensive communication programmes and workshops underway
2010 Focus
Enhance our anti-illicit trade activities and improve monitoring of compliance with our IMS
CR Framework – Important issues
Employment practices
- General employment practices
- Equal opportunities and non-discrimination
- Pay and benefits
- Responsible restructuring
2009 Focus
- Organisational change and integration of Altadis
2009 Progress
- Planned integration projects successfully concluded in France and Spain, and social plans implemented
2010 Focus
Complete planned organisational changes and integration of Imperial Tobacco and Altadis
CR Framework – Important issues
Occupational health and safety (OHS):
- Employee health and safety
2009 Focus
- Revitalisation of OHS management
2009 Progress
- Implemented more rigorous performance review and site improvement planning, and continued employee training programmes
2010 Focus
Further develop our OHS processes
More information on our occupational health and safety (OHS)
CR Framework – Important issues
Supplier relationships
and accountability:
- Social responsibility in tobacco production
- Non-tobacco materials supply
2009 Focus
- Supplier standards (social, environmental and economic)
2009 Progress
- Further development of procurement and standards inclusive of all purchase types, and sharing of best-practice approaches
2010 Focus
Continue engagement with partners to improve social and environmental standards in the supply chain
More information on our supplier relationships and accountability
CR Framework – Important issues
Environmental impact:
- Environmental management
- Energy use and climate change
- Environmental waste
- Product and packaging waste
2009 Focus
- Climate change and carbon management
2009 Progress
- Roll-out of measurement and monitoring, and resetting of baselines to enable Group-wide reporting and environmental reduction targeting
2010 Focus
Further develop our environmental processes
CR Framework – Important issues
Community involvement:
- Community investment
- Charitable donations
2009 Focus
- Integration of community investment and engagement activities
2009 Progress
- Developed new guidelines and performance measures, and brought Altadis Foundation into community investment structure
2010 Focus
Consider opportunities to enhance community involvement and better communicate positive contributions
* Our future focus is under review in light of the integration of Imperial Tobacco and Altadis, and the progress we have already made.
